Physician profile
William T Scott
NPI 1083614309
$1,241.05
in general payments reported to CMS, 2019-2025
29 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $57.55 · 2021: $58.40 · 2022: $301 · 2023: $275 · 2024: $83.07 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $196.22 | 2019-2025 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $169.72 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $108.65 | 2019-2025 | |
| Gynesonics, INC. | $103.45 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Coopersurgical, INC. | $81.94 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $53.20 | 2021-2024 | |
| Sage Therapeutics, LLC | $48.93 | 2022-2023 | |
| Amgen INC. | $47.06 | 2019-2025 | Evenity |
| Merck Sharp & Dohme LLC | $46.25 | 2019-2022 | |
| Covidien LP | $39.80 | 2019 | |
| Hologic Sales and Service, LLC | $36.46 | 2019-2023 | Thinprep 2000 Processor, Aptima |
| Sumitomo Pharma America, INC. | $35.24 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $29.65 | 2023 | |
| Minerva Surgical, INC | $25.12 | 2019-2020 | |
| Allergan, INC. | $19.36 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18.12 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $17.63 | 2022 | |
| Solventum Corporation | $17.49 | 2025 | Prevena, V.A.C.Ulta |
| Pfizer INC. | $17.04 | 2023 | |
| Mycovia Pharmaceuticals, INC. | $16.63 | 2022 | |
| Amag Pharmaceuticals, INC. | $15.00 | 2019 | |
| Duchesnay USA Incorporated | $14.52 | 2019 | |
| Myovant Sciences INC. | $14.27 | 2022 | |
| Meditrina | $13.62 | 2022 | |
| Avion Pharmaceuticals | $12.97 | 2022 | |
| Kci USA, INC. | $12.90 | 2023 | Prevena |
| Lupin INC. | $12.18 | 2019 | |
| Therapeuticsmd, INC. | $11.60 | 2019 | |
| Allotrope Medical, INC | $6.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.